Cargando…
Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa Cells
Cisplatin along with other platinum based drugs are some of the most widely used chemotherapeutic agents. However drug resistance is a major problem for the successful chemotherapeutic treatment of cancer. Current evidence suggests that drug resistance is a multifactorial problem due to changes in t...
Autores principales: | Chavez, Juan D., Hoopmann, Michael R., Weisbrod, Chad R., Takara, Kohji, Bruce, James E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102677/ https://www.ncbi.nlm.nih.gov/pubmed/21637840 http://dx.doi.org/10.1371/journal.pone.0019892 |
Ejemplares similares
-
Exploring the HeLa Dark Mitochondrial Proteome
por: Marini, Federica, et al.
Publicado: (2020) -
Cisplatin‐resistant HeLa Cells Are Resistant to Apoptosis via p53‐dependent and ‐independent Pathways
por: Minagawa, Yukihisa, et al.
Publicado: (1999) -
Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells
por: Minagawa, Yukihisa, et al.
Publicado: (1994) -
Hypoxia Strongly Affects Mitochondrial Ribosomal Proteins and Translocases, as Shown by Quantitative Proteomics of HeLa Cells
por: Bousquet, Paula A., et al.
Publicado: (2015) -
Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa
por: Zhuang, Liang, et al.
Publicado: (2018)